XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statement of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Receipts on Account of Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 [1] $ 112,986,000 $ 48,000 $ 16,000 $ (109,853,000) $ 3,197,000
Balance, shares at Dec. 31, 2023 3,482          
Loss for the period (12,503,000) (12,503,000)
Other comprehensive income (11,000) (11,000)
Stock-based compensation 239,000 239,000
Issuance of restricted shares as compensation towards directors [1] 126,000 (48,000) 78,000
Issuance of restricted shares as compensation towards directors, shares 73          
Restricted shares to be issued as compensation towards directors 100,000 100,000
Issuance of Common Stock upon private placement transaction [1] 500,000     500,000
Issuance of Common Stock upon private placement transaction, shares 67          
Issuance of restricted shares as payment for a previous achievement of milestone pursuant to purchase agreement [1]
Issuance of restricted shares as payment for a previous achievement of milestone pursuant to purchase agreement, shares 17          
Exercise of prefunded warrants into shares [1]
Exercise of prefunded warrants into shares, shares 330          
Exchange of warrants into shares [1]
Exchange of warrants into shares, shares 599          
Issuance of detachable warrants through private placements transactions   2,635,000       2,635,000
Issuance of shares and warrants as settlement of financial liabilities [1] 1,743,000 1,743,000
Issuance of shares and warrants as settlement of financial liabilities, shares 243          
Balance at Sep. 30, 2024 118,229,000 100,000 5,000 (122,356,000) (4,022,000)
Balance, shares at Sep. 30, 2024 4,811          
Balance at Jun. 30, 2024 [1] 113,908,000 50,000 22,000 (117,269,000) (3,289,000)
Balance, shares at Jun. 30, 2024 4,568          
Loss for the period (5,087,000) (5,087,000)
Other comprehensive income     (17,000) (17,000)
Stock-based compensation 11,000 11,000
Restricted shares to be issued as compensation towards directors     50,000 50,000
Issuance of detachable warrants through private placements transactions [1] 2,567,000   2,567,000
Issuance of shares and warrants as settlement of financial liabilities [1] 1,743,000 1,743,000
Issuance of shares and warrants as settlement of financial liabilities, shares 243          
Balance at Sep. 30, 2024 118,229,000 100,000 5,000 (122,356,000) (4,022,000)
Balance, shares at Sep. 30, 2024 4,811          
Balance at Dec. 31, 2024 [1] 119,230,000 228,000 (8,000) (132,450,000) (13,000,000)
Balance, shares at Dec. 31, 2024 13,409          
Loss for the period (15,760,000) (15,760,000)
Other comprehensive income 50,000 50,000
Stock-based compensation 121,000 121,000
Issuance of Common Stock upon the completion of public offerings, net of offering expenses of $539 $ 1,000 10,714,000 10,715,000
Issuance of Common Stock upon the completion of public offerings, net of offering expenses of $539, shares 665,052          
Stock split adjustment [1]
Stock split adjustment, shares 58,886          
Cashless exchange of warrants into Common Stock [1] 20,625,000 20,625,000
Cashless exchange of warrants into Common Stock, shares 162,063          
Balance at Sep. 30, 2025 $ 1,000 150,690,000 228,000 42,000 (148,210,000) 2,751,000
Balance, shares at Sep. 30, 2025 899,410          
Balance at Jun. 30, 2025 [1] 150,649,000 228,000 41,000 (144,039,000) 6,880,000
Balance, shares at Jun. 30, 2025 899,410          
Loss for the period (4,171,000) (4,171,000)
Other comprehensive income 1,000 1,000
Stock-based compensation 41,000 41,000
Balance at Sep. 30, 2025 $ 1,000 $ 150,690,000 $ 228,000 $ 42,000 $ (148,210,000) $ 2,751,000
Balance, shares at Sep. 30, 2025 899,410          
[1] Represents amount lower than $1.